Cas 741663-27-4,3-({1-(3-({((2-furylmethyl)amino)thioxomethyl}amino)phenyl)-5-oxopyrrolidin-3-yl}carbonylamino)-3-(3-pyridyl)propanoic acid

741663-27-4

Post Buying Request

Basic information

Product Name: 3-({1-(3-({((2-furylmethyl)amino)thioxomethyl}amino)phenyl)-5-oxopyrrolidin-3-yl}carbonylamino)-3-(3-pyridyl)propanoic acid
Synonyms:
CAS NO:741663-27-4
Molecular Formula:
Molecular Weight: 507.57
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-({1-(3-({((2-furylmethyl)amino)thioxomethyl}amino)phenyl)-5-oxopyrrolidin-3-yl}carbonylamino)-3-(3-pyridyl)propanoic acid(CAS DataBase Reference)
NIST Chemistry Reference: 3-({1-(3-({((2-furylmethyl)amino)thioxomethyl}amino)phenyl)-5-oxopyrrolidin-3-yl}carbonylamino)-3-(3-pyridyl)propanoic acid(741663-27-4)
EPA Substance Registry System: 3-({1-(3-({((2-furylmethyl)amino)thioxomethyl}amino)phenyl)-5-oxopyrrolidin-3-yl}carbonylamino)-3-(3-pyridyl)propanoic acid(741663-27-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 741663-27-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

741663-27-4 Suppliers

Recommended suppliers

741663-27-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 741663-27-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,1,6,6 and 3 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 741663-27:
(8*7)+(7*4)+(6*1)+(5*6)+(4*6)+(3*3)+(2*2)+(1*7)=164
164 % 10 = 4
So 741663-27-4 is a valid CAS Registry Number.

741663-27-4Upstream product

741663-27-4Downstream Products

741663-27-4Relevant academic research and scientific papers

Integrin inhibitors and their methods of use

-

, (2008/06/13)

The invention comprises novel compounds that are effective in the prophylaxis and treatment of diseases, such as integrin receptors mediated diseases, in particular, diseases or conditions mediated by integrin receptors, such as a αvβ3, αvβ6, α5β1 and the like. The invention encompasses novel compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of such diseases and disorders. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 741663-27-4